Holy Family Hospital

Holy Family Hospital

70 East Street, Methuen, MA 01844
978-687-0151

Print This Page Share This Page

Holy Family Hospital - Site Map

(Expand All | Collapse All)

  • Home Page
  • Health & Wellness
  • Our Web Pages
  • Event Calendar
  • News Center
  • Clinical Trials
  • Physician Directory
  • *Other Programs & Services
  • Adolescent Medicine
  • Alergias y Asma
  • Alergias, Asma y Inmunología
  • Allergy and Asthma
  • Allergy and Immunology
  • Allergy, Asthma, and Immunology
  • Andover Surgery Center
  • Anesthesiology
  • Anomalías Craneofaciales
  • Arthritis and Other Rheumatic Diseases
  • Artritis y Otras Enfermedades Reumáticas
  • Artritis y Otras Enfermedades Reumáticas Pediátricas
  • Bariatric Medicine
  • Birthing Center
  • Bone Disorders
  • Breast Health
  • Burns
  • Cáncer de Piel
  • Cancer Care
  • Cancer Center
  • Cardiothoracic/Thoracic Surgery
  • Cardiovascular Diseases
  • Cardiovascular Disorders
  • Cardiovascular Medicine
  • Cardiovascular Tests and Procedures
  • Care of the Terminally Ill Child
  • Caritas Holy Family
  • Child and Adolescent Mental Health
  • Cirugía Ortopédica
  • Cirugía Plástica
  • Clinical Trials and Research
  • Common Childhood Injuries and Poisonings
  • Complementary and Alternative Medicine
  • Content Library of Adult English Medical Content
  • Content Library of Adult Spanish Medical Content
  • Content Library of Ped English Medical Content
  • Content Library of Ped Spanish Medical Content
  • Content Library of the Cancer Center Medical Content
  • Content Library of the Heart Center Medical Content
  • Content Library of the Orthopaedic Center Medical Content
  • Content Library of the Pregnancy Center Medical Content
  • Content Library of the Women's Center Medical Content
  • Craniofacial Anomalies
  • Crecimiento y Desarrollo
  • Cuidado de Ojos
  • Cuidado de Ojos
  • Cuidado del Niño con Enfermedad Terminal
  • Cuidado Quirúrgico
  • Dental and Oral Health
  • Dermatología
  • Dermatología
  • Dermatology
  • Dermatology
  • Dermatology
  • Diabetes
  • Diabetes
  • Diabetes
  • Diabetes and Other Endocrine and Metabolic Disorders
  • Diabetes y Otros Trastornos Endocrinos y Metabólicos
  • Diagnostic Imaging
  • Digestive and Liver Disorders
  • Digestive Diseases
  • Digestive Disorders
  • Disease and Wellness
  • Ear, Nose and Throat
  • Ear, Nose, and Throat
  • Embarazo de Alto Riesgo
  • Embarazo y Nacimiento
  • Embarazo y Nacimiento
  • Emergencias No-Traumáticas
  • Emergency Medicine
  • Emergency Medicine
  • Endocrinología
  • Endocrinology
  • Endocrinology
  • Endocrinology
  • Enfermedades Cardiovasculares
  • Enfermedades del Aparato Digestivo
  • Enfermedades del Hígado, Bilis y Páncreas
  • Enfermedades Infecciosas
  • Enfermedades Infecciosas
  • Environmental Medicine
  • Eye Care
  • Eye Care
  • For Professionals
  • Gastroenterology
  • Gastroenterology Tests and Procedures
  • Genética Médica
  • General Surgery
  • Genitourinary and Kidney Disorders
  • Glossary
  • Growth and Development
  • Gynecological Health
  • Gynecology Tests and Procedures
  • Heart Care
  • Heart Center
  • Hematología y Enfermedades de Sangre
  • Hematología y Trastornos de Sangre
  • Hematology and Blood Disorders
  • Hematology and Blood Disorders
  • Hematology/Oncology
  • High-Risk Newborn
  • High-Risk Pregnancy
  • Home Health, Hospice, and Elder Care
  • Infectious Disease
  • Infectious Diseases
  • Infectious Diseases
  • Internal Medicine
  • Internal Medicine, Family Medicine and Primary Care
  • Kidney and Urinary System Disorders
  • Lesiones y Intoxicaciones Frecuentes en Niñez
  • Liver, Biliary, and Pancreatic Disorders
  • Maternal Fetal Medicine
  • Media Coverage Pages
  • Medical Genetics
  • Medicina Complementaria Y Alternativa
  • Medicina del Adolescente
  • Medicina del Medio Ambiente
  • Medicina Física y Rehabilitacián
  • Medicina para Viajero
  • Men's Health
  • Mental Health Disorders
  • Mission & Values
  • Neonatology
  • Nephrology
  • Nervous System Disorders
  • Neurological Disorders
  • Neurological Tests and Procedures
  • Neurology
  • Neurosciences
  • Neurosurgery
  • Newsroom
  • Niño que se Somete a Cirugía
  • Non-Traumatic Emergencies
  • Normal Newborn
  • Nuclear Medicine
  • Oído, Nariz y Garganta
  • Obstetrics and Gynecology
  • Oncología
  • Oncology
  • Ophthalmology
  • Oral and Maxillofacial Surgery
  • Oral Health
  • Orthopaedic Center
  • Orthopaedic Surgery
  • Orthopaedic Tests and Procedures
  • Orthopaedics
  • Orthopedic Surgery
  • Orthopedics
  • Ortopedia
  • Otolaryngology
  • Otolaryngology
  • Otorrinolaringología
  • Pain Management
  • Pain Management
  • Pathology
  • Pathology
  • Patient and Visitor Information
  • Patológica
  • Pediatría
  • Pediatric Arthritis and Other Rheumatic Diseases
  • Pediatrics
  • Pediatrics
  • Pediatrics
  • Physical Medicine and Rehabilitation
  • Physical Medicine and Rehabilitation
  • Plastic Surgery
  • Plastic Surgery
  • Plastic Surgery
  • Podiatry
  • Pregnancy and Childbirth
  • Pregnancy and Childbirth
  • Pregnancy, Birth, and Baby Center
  • Prostate Health
  • Psychiatry
  • Psychiatry
  • Pulmonary Medicine
  • Pulmonary Medicine and Critical Care
  • Pulmonary Tests and Procedures
  • Quality
  • Quality and Clinical Excellence
  • Quality and Patient Satisfaction
  • Quemaduras
  • Radiation Oncology
  • Radiología
  • Radiology
  • Recién Nacido de Alto Riesgo
  • Recién Nacido Normal
  • Rehabilitation & Physical Therapy
  • Respiratory Disorders
  • Respiratory Disorders
  • Rheumatology
  • Safety and Injury Prevention
  • Salud de Hombres
  • Salud de Mujeres
  • Salud de Prástata
  • Salud del Seno
  • Salud en Hogar, Hospicio y Cuidado de Ancianos
  • Salud Ginecológica
  • Salud Mental de Niños y Adolescentes
  • Salud Oral
  • Salud Oral y de Dientes
  • Seguridad y Prevención de Lesiones
  • Services and Clinical Centers
  • Skin Cancer
  • Sleep Medicine
  • Spine, Shoulder, and Pelvis Disorders
  • Surgery
  • Surgical Care
  • Tests and Procedures
  • The Child Having Surgery
  • Thoracic Surgery
  • Transplantation
  • Trasplantes
  • Trastornos Cardiovasculares
  • Trastornos de Columna Vertebral, Hombro y Pelvis
  • Trastornos de Huesos
  • Trastornos de Salud Mental
  • Trastornos del Riñón y el Aparato Urinario
  • Trastornos del Sistema Nervioso
  • Trastornos Digestivos y Hepáticos
  • Trastornos Genitourinarios y de Riñones
  • Trastornos Neurológicos
  • Trastornos Respiratorios
  • Trastornos Respiratorios
  • Travel Medicine
  • Urology
  • Urology
  • Urology Tests and Procedures
  • Vascular Surgery
  • Vascular Surgery
  • Ways of Giving
  • Welcome Newborn
  • Women's Center
  • Women's Health
  • Women's Health
  • Wound Clinic
  • AWAKE Sleep Apnea Support Group
  • Care For Cancer 3-Mile Walk/Fun Run
  • Care For Cancer 24-Hour Spin-a-Thon
  • Skin Cancer Screening
  • Back Pain and Spine Injury Prevention
  • Diabetes Support Group Lecture Series - Know Your Options
  • Managing Menopause
  • Diabetes Support Group Lecture Series - Know Your Healthy Steps
  • Head and Neck Cancer Screening
  • Diabetes Support Group Lecture Series - Know Your Nutrition
  • Breast Cancer Awareness
  • Diabetes Support Group Lecture Series - Know Your Resistance
  • SHARE - A Perinatal Loss Support Group
  • Diabetes and Exercise
  • Spring Training with the Docs: A Coaches’ Clinic on Shoulder Injuries Caused by Throwing
  • Diabetes Support Group Lecture Series - Know Your Options
  • Community Diabetes Screening
  • Diabetes Support Group Lecture Series - Know Your Healthy Steps
  • Angela Pisick Cancer Support Group
  • Crohn's & Colitis Foundation of America Support Group
  • Sheila Brodie-Zetlan Breast Cancer Support Group
  • Bereavement Support Group
  • Diabetes Support Group Lecture Series - Know Your Nutrition
  • Fall Prevention and Osteoporosis
  • Community Diabetes Screening
  • Responsible Fatherhood Program
  • Holy Family Hospital Launches Electronic Medical Record
  • Moody’s Investor Service Upgrades Caritas Christi Health Care System Bond Rating
  • Holy Family Hospital Helps Keep Community Healthy
  • Holy Family Establishes Regional Center for Orthopedic Care
  • Holy Family Hospital Welcomes New Orthopedic Spine Physician Group
  • Caritas Christi Launches Relief Effort in Haiti
  • Caritas Christi Health Care and Philips Healthcare Team Up in Significant Haiti Relief Effort
  • For Emergency Relief Workers Traveling to Haiti
  • Merrimack Valley YMCA Announces New Board of Trustee and Board of Director Members
  • Holy Family Hospital Acquires Andover Surgery Center
  • Christmas Comes Early for Holy Family Hospital Foundation
  • Holy Family Hospital Takes Major Step Forward in Preventing Infection
  • Norwood Hospital Wins 2009 Leapfrog Award
  • Success of Primary Angioplasty Program Leads to Comprehensive, Independent Cardiology Services at Holy Family Hospital
  • Blue Cross Blue Shield of MA and Caritas Christi Healthcare Aim to Alter Healthcare Fee Model
  • Holy Family Hospital Partners with Merrimack Valley YMCA to Offer Comprehensive Diabetes Awareness Program
  • Holy Family Hospital to Host Women’s Health and Wellness Fair
  • Holy Family Hospital and Merrimack Valley YMCA Launch Official Community Health Partnership
  • Holy Family Hospital "Night of Champions" Party Set for September 27
  • Holy Family Announces the Merrimack Valley’s First Comprehensive Pain Program with Full Medical Management
  • Holy Family Hospital Adds “Cooling Therapy” to Treat Heart Attack Victims
  • Holy Family Welcomes Cancer Specialist
  • Holy Family Plans for New Emergency Department
  • H1N1 Flu (Swine Flu) - Caritas Christi Monitoring Status
  • Bone & Joint Team Now Offering Hip Resurfacing Treatment
  • For Clinicians
  • Holy Family Hospital Announces Acquisition of the Highly Advanced Trilogy Stereotactic System for Treating Cancer and Other Conditions
  • Holy Family Hospital Opens New MRI Suite
  • Caritas Christi Pledges To Bring Quality To the People
  • Holy Family Hospital Announces 2009 Bone & Joint Lecture Series
  • Care for Cancer Walk Back to May by Popular Demand
  • "Teddy Bear Clinic" for Kids and Families - Saturday, February 21, 11 a.m. to 3 p.m.
  • Holy Family Hospital Announces Expansion of Women's Health Center
  • Boston Celtics Legend JoJo White Teams with Holy Family Hospital for the Inaugural JoJo White Celebrity Golf Classic
  • Holy Family Hospital Welcomes Two New Physicians
  • Dancing with the Hospital Stars Event to Take Place Friday, October 3, 2008
  • Join the American Heart Association
  • Holy Family Hospital Teams up with Massachusetts General Hospital for Stroke Services
  • Holy Family Hospital Appoints CFO, Director of Foundation
  • 22nd Annual Holy Family Men's Guild Golf Tournament, June 9
  • Emergency Preparedness Week, June 1-6, 2008
  • Holy Family Hospital 22nd Annual Golf Tournament Set for June 9, 2008
  • Kick the Habit: Quit Smoking, January 5 - February 23
  • Holy Family Hospital and Lawrence General Hospital to Launch Joint Primary (Emergency) Angioplasty Program
  • Caritas Christi Health Care names Ralph de la Torre, M.D. as its president and CEO
  • Caritas Holy Family Launches New Branding Campaign
  • Holy Family to Acquire New Cancer Treatment Technology
  • Caritas Holy Family Partners With Children's Hospital
  • Caritas Christi Names Longtime Merrimack Valley Health Care Executive as President of Caritas Holy Family Hospital and Medical Center
  • Caritas Holy Family Hospital Wound/Ostomy Specialist Named Outstanding Nurse of the Year by Wound Ostomy & Continence Nurses Society
  • Caritas Holy Family Celebrates Win For Women's Health In Merrimack Valley
  • Caritas Holy Family Hospital Sleep Lab Director Receives American College of Chest Physicians Grant For Caritas Centers for Sleep Medicine
  • (CLOSURE I) A Prospective, Multicenter, Randomized Controlled Trial to Evaluate the Safety and Efficacy of the STARFlex® Septal Closure System Versus Best Medical Therapy in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale
  • "IMMEDIATE Trial" GLUCOSE-INSULIN-POTASSIUM (GIK) IMMEDIATE MYOCARDIAL METABOLIC ENHANCEMENT DURING INITIAL ASSESSMENT AND TREATMENT IN EMERGENCY CARE
  • 24-Hour Spin Away Cancer
  • 24-Hour Spin Away Cancer
  • 3D Conformal Radiation Therapy
  • A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
  • A 24-month Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing the Efficacy and Safety of 0.5 mg and 1.25 mg Fingolimod (FTY720) Administered Orally Once Daily Versus Placebo in Patients With Relapsing-remitting Multiple Sclerosis.
  • A Clinical Trial Comparing Anastrozole With Tamoxifen in Postmenopausal Patients With Ductal Carcinoma in Situ (DCIS) Undergoing Lumpectomy With Radiation Therapy
  • A Clinical Trial Comparing Preoperative Radiation Therapy And Capecitabine With or Without Oxaliplatin With Preoperative Radiation Therapy And Continuous Intravenous Infusion Of 5-Fluorouracil With or Without Oxaliplatin In The Treatment Of Patients With Operable Carcinoma Of The Rectum
  • A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
  • A Clinical Trial to Determine the Efficacy of Five Years of Letrozole Compared to Placebo in Patients Completing Five Years of Hormonal Therapy Consisting of an Aromatase Inhibitor (AI) or Tamoxifen Followed By an AI in Prolonging Disease-Free Survival in Postmenopausal Women With Hormone Receptor Positive Breast Cancer
  • A Comparison of the CNS Effects of Equivalent Doses of Escitalopram and Racemic Citalopram Using BOLD fMRI
  • A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto-CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
  • A Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing the Efficacy and Safety of 1.25mg FTY720 Administered Orally Once Daily Versus Placebo in Patients With Primary Progressive Multiple Sclerosis.
  • A Double-Blind, Randomized, Placebo-Controlled Phase III Trial of Carboplatin, Paclitaxel, and BAY 43-9006 Versus Carboplatin, Paclitaxel, and Placebo in Patients With Unresectable Stage III or IV Melanoma
  • A Dual-Cohort, Prospective, Observational Study of Unresectable Stage IIIB/IV Non-Small Cell Lung Cancer Patients With and Without Bone Metastasis
  • A healing touch: Wound nurse puts ostomy, amputee patients on road to emotional recovery
  • A Magnetic Resonance Spectroscopy and fMRI Study of the Effects of Lisdexamfetamine on Bipolar Depression
  • A Multicenter, Randomized, Double-Blind, Placebo-Controlled Staggered Dose-Escalating Phase IIb Study of the Safety and Efficacy of Istaroxime Over 24 Hours at Three Doses in Acute Decompensated Heart Failure Patients (The IGNITE Trial)
  • A multicenter, randomized, double-blind, placebo-controlled study of the effects of KW-3902 Injectable Emulsion on heart failure signs and symptoms, diuresis, renal function, and clinical outcomes in subjects hospitalized with worsening renal function and heart failure requiring intravenous therapy.
  • A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter, Dose-Selection Study of Ad2/Hypoxia Inducible Factor (HIF)-1α/VP16 in Patients With Intermittent Claudication
  • A Phase 3 Randomized, Rater-Blinded Study Comparing Two Annual Cycles of Intravenous Alemtuzumab to Three-Times Weekly Subcutaneous Interferon Beta-1a (Rebif®) in Treatment-Naïve Patients With Relapsing-Remitting Multiple Sclerosis
  • A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
  • A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer
  • A Phase II Evaluation of Preoperative Chemoradiotherapy Utilizing Intensity Modulated Radiation Therapy (IMRT) in Combination With Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer
  • A Phase II Randomized Trial Of Surgery Followed By Chemoradiotherapy Plus Cetuximab For Advanced Squamous Cell Carcinoma Of The Head and Neck
  • A Phase II Study of Induction Chemotherapy Followed by Thoracic Radiotherapy and Erlotinib in Poor-Risk Stage III Non-Small Cell Lung Cancer
  • A Phase II Study Of Tirapazamine (NSC-130181)/Cisplatin/Etoposide And Concurrent Thoracic Radiotherapy For Limited Stage Small Cell Lung Cancer
  • A Phase II Trial of 5-Fluorouracil, Leucovorin, and Oxaliplatin (mFOLFOX6) Chemotherapy Plus Bevacizumab for Patients With Unresectable Stage IV Colon Cancer and a Synchronous Asymptomatic Primary Tumor
  • A Phase II Trial of Novel Oral Anti-Angiogenic Agent AZD2171 (NSC-732208) in Malignant Pleural Mesothelioma
  • A Phase II Trial of Samarium 153 Followed by Salvage Prostatic Fossa 3DCRT or IMRT Irradiation in High-Risk, Clinically Non-Metastatic Prostate Cancer After Radical Prostatectomy
  • A Phase II/III Randomized Trial Of Two Dose Schedules For Delivering Prophylactic Cranial Irradiation For Patients With Limited Disease Small Cell Lung Cancer
  • A Phase III Biomarker Validation Study of Second-line Therapy in Patients With Advanced Non- Small Cell Lung Cancer (NSCLC) Randomized to Pemetrexed Versus Erlotinib
  • A Phase III Clinical Trial Comparing Infusional 5-Fluorouracil (5-FU), Leucovorin, and Oxaliplatin (mFOLFOX6) Every Two Weeks With Bevacizumab to the Same Regimen Without Bevacizumab for the Treatment of Patients With Resected Stages II and III Carcinoma of the Colon
  • A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently With Radiation Therapy and Radiation Therapy Alone for Women With HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy
  • A Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy With or Without Short-Term Androgen Deprivation Therapy for Patients With Intermediate-Risk Prostate Cancer
  • A Phase III Protocol of Androgen Suppression (AS) and 3DCRT/IMRT Vs AS and 3DCRT/IMRT Followed by Chemotherapy With Docetaxel and Prednisone for Localized, High-Risk, Prostate Cancer
  • A Phase III Randomized Double Blind Study of Vorozole Versus Placebo in Women With Primary Breast Cancer Completing Five or More Years of Adjuvant Tamoxifen
  • A Phase III Randomized Open-Label Study Comparing Gemcitabine Plus Cetuximab (IMC-C225) Versus Gemcitabine As First-Line Therapy Of Patients With Advanced Pancreas Cancer
  • A Phase III Randomized Study of 5-Fluorouracil, Mitomycin-C, and Radiotherapy Versus 5-Fluorouracil, Cisplatin, and Radiotherapy in Carcinoma of the Anal Canal
  • A Phase III Randomized Study of Hypofractionated 3D-CRT/IMRT Versus Conventionally Fractionated 3D-CRT/IMRT in Patients With Favorable-Risk Prostate Cancer
  • A Phase III Randomized Trial of Lobectomy Versus Sublobar Resection for Small (≤ 2 CM) Peripheral Non-Small Cell Lung Cancer
  • A Phase III Study Comparing Combined External Beam Radiation and Transperineal Interstitial Permanent Brachytherapy With Brachytherapy Alone for Selected Patients With Intermediate Risk Prostatic Carcinoma
  • A Phase III Study of the Addition of Gemtuzumab Ozogamicin (Mylotarg®) During Induction Therapy Versus Standard Induction With Daunomycin and Cytosine Arabinoside Followed by Consolidation and Subsequent Randomization to Post-Consolidation Therapy With Gemtuzumab Ozogamicin (Mylotarg®) or No Additional Therapy For Patients Under Age 61 With Previously Untreated De Novo Acute Myeloid Leukemia (AML)
  • A Phase III Trial of CHOP Plus Rituximab vs CHOP Plus Iodine-131-Labeled Monoclonal Anti-B1 Antibody (Tositumomab) for Treatment of Newly Diagnosed Follicular Non-Hodgkin's Lymphomas
  • A Phase III Trial of Concurrent Radiation and Chemotherapy for Advanced Head and Neck Carcinomas
  • A Phase III Trial of Irinotecan / 5-FU / Leucovorin or Oxaliplatin / 5-FU/ Leucovorin With Bevacizumab, or Cetuximab (C225), or With the Combination or Bevacizumab and Cetuximab for Patients With Untreated Metastatic Adenocarcinoma of the Colon or Rectum
  • A Phase III Trial of Short Term Androgen Deprivation With Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPPORT) in Prostate Cancer Patients With a Rising PSA After Radical Prostatectomy
  • A Phase III, Open-Label Study of Tenecteplase for Restoration of Function in Dysfunctional Hemodialysis Catheters
  • A Phase IIIb, randomized, double blind, parallel-group, multi-center study to assess the efficacy and safety of multiple 30-minute infusions of Conivaptan in subjects with euvolemic or hypervolemic hyponatremia
  • A Pilot (Phase I) Study of Weekly Docetaxel and Cetuximab Chemoradiation for Poor Risk Stage III Non-Small Cell Lung Cancer
  • A pilot study evaluating the safety of avastin and pelvic radiation in women with pelvic-confined recurrence of gynecological cancers
  • A Pilot Trial of Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Docetaxel and the Addition of Bevacizumab (NSC-704865) in Three Cohorts of Patients With Inoperable Locally Advanced Stage III Non-Small Cell Lung Cancer
  • A pivotal study to evaluate the effectiveness and safety of ExAblate treatment of metastatic bone tumors for the palliation of pain in patients who are not candidates for radiation therapy
  • A Prospective, Randomized, Double-Blind, Double-Dummy, Parallel-Group, Multicenter, Event-Driven, Non-Inferiority Study Comparing the Efficacy and Safety of Once-Daily Oral Rivaroxaban (BAY 59-7939) With Adjusted-Dose Oral Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Subjects With Non-Valvular Atrial Fibrillation
  • A Prospective, Randomized, Double-blind, Stratified, Multi-center, 2-arm Trial of the Continued Efficacy and Safety of Zoledronic Acid (Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Breast Cancer
  • A Prospective, Randomized, Multicenter, Open Label, Pilot Study to Evaluate the ROX Anastomotic Coupler System in Patients With Chronic Obstructive Pulmonary Disease
  • A Randomized Controlled Trial of Radiofrequency Ablation for the Treatment of Paroxysmal Atrial Fibrillation Using the Bard High Density Mesh Ablation System (MAGELLAN)
  • A Randomized Double-Blinded Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab to Gemcitabine, Cisplatin, and Placebo in Patients With Advanced Transitional Cell Carcinoma
  • A Randomized Phase II Study of Radiation Therapy, Pemetrexed and Carboplatin With or Without Cetuximab in Stage III Non-Small Cell Lung Cancer
  • A Randomized Phase III Study Comparing 5-FU, Leucovorin and Oxaliplatin Versus 5-FU, Leucovorin, Oxaliplatin and Bevacizumab in Patients With Stage II Colon Cancer at High Risk for Recurrence to Determine Prospectively the Prognostic Value of Molecular Markers
  • A randomized phase III trial of neoadjuvant therapy for patients with palpable and operable HER-2 positive breast cancer comparing the combination of trastuzumab plus lapatinib to trastuzumab and to lapatinib administered with weekly paclitaxel following AC accompnied by correlative science studies to identify predictors of pathologic complete response
  • A Randomized Trial of Adjuvant Chemotherapy With Standard Regimens, Cyclophosphamide, Methotrexate and Fluorouracil - (CMF) or Doxorubicin and Cyclophosphamide - (AC), Versus Capecitabine in Women 65 Years and Older With Node Positive or Node-Negative Breast Cancer
  • A Randomized, Double-Blind, Placebo Controlled, Cross-over Study of the Effectiveness of Immune Globulin Intravenous (Human), 10% (IGIV, 10%) for the Treatment of Multifocal Motor Neuropathy
  • A Randomized, Double-Blind, Placebo-Controlled, Cross-Over, Multi-Center Study of Eculizumab in Patients With Generalized Myasthenia Gravis (gMG) Who Have Moderate to Severe Muscle Weakness Despite Treatment With Immunosuppressants
  • A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Anamorelin HCl Dose Range Study to Evaluate the Safety and Efficacy of Anamorelin HCl in Patients With NSCLC
  • A Randomized, Double-Blind, Placebo-Controlled, Phase IIIb Trial Comparing Bevacizumab Therapy With or Without Erlotinib After Completion of Chemotherapy With Bevacizumab for the First-Line Treatment of Locally Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer
  • A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Dose-Comparison Study to Determine the Efficacy and Safety of BG00012 in Subjects with Relapsing-Remitting Multiple Sclerosis
  • A Randomized, Prospective, Double-Blinded, Placebo-Controlled (Sham-Controlled) Study to Evaluate the Safety and Effectiveness of the Adacolumn Apheresis System for the Treatment of Moderate to Severe Ulcerative Colitis
  • A Randomized, Single-blind, Placebo-controlled, 4-Week Treatment Study of the Safety and Biologic Activity of Escalating Multiple Oral Doses of FG-4592 in Subjects with Chronic Kidney Disease Not Requiring Dialysis
  • A Randomized, Single-blind, Placebo-controlled, 4-Week Treatment Study of the Safety and Biologic Activity of Escalating Multiple Oral Doses of FG-4592 in Subjects with Chronic Kidney Disease Not Requiring Dialysis
  • A safe approach to treating kids’ colds and flu
  • A Statewide Partnerships for Worksite Weight Management Grant Project
  • About Us
  • Adjuvant 3DCRT/IMRT in Combination With Androgen Suppression and Docetaxel for High Risk Prostate Cancer Patients Post-Prostatectomy: A Phase II Trial
  • Alcoholics Anonymous
  • An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy for Treatment of Metastatic or Locally Advanced and Unresectable Colorectal Cancer and Locally Advanced or Metastatic Non-Small Cell Lung (Excluding Predominant Squamous Cell Histology)
  • An Open-Label, Multicenter Study to Determine Subject Satisfaction in Using the Single-Use Autoinjector with a Pre-Filled Liquid Avonex® Syringe in Multiple Sclerosis
  • Andover Surgery Center
  • Annual Report
  • As seen on TV: Real-life health care workers say medical shows aren't telling the real story
  • Ask the expert: Some drugs safe to take in pregnancy
  • Audiology
  • AVAIL CLS/CRT: AV-Node Ablation With CLS and CRT Pacing Therapies for the Treatment of AF
  • Baby Care Basics
  • Bancroft kindergarteners learn about the operating room
  • Bancroft students make the rounds at hospital
  • Barbecues and Summer Eating with Diabetes
  • Bariatric
  • Batterer Intervention
  • Behavioral Health
  • Billing and Payment
  • Birthing Center
  • Birthing Center: Birth Certificates
  • Birthing Center: Maternal-Fetal Medicine
  • Birthing Center: Online Class Registration
  • Birthing Center: Pre-Admission Form
  • Birthing Center: Questions & Answers
  • Birthing Center: Related Links
  • Birthing Center: Testimonials
  • Birthing Center: Virtual Tour
  • Birthing Center: Welcome Newborn
  • Board of Trustees
  • Bob Kotsonis, CFO
  • Bone & Joint Team
  • Bone & Joint Team: Bone & Joint Class
  • Bone & Joint Team: Home Healthcare
  • Bone & Joint Team: Pre-Surgery Checklist
  • Bone & Joint Team: Surgery/Inpatient Care
  • Bone & Joint Team: Transitional Care (TCU)
  • Bone Density
  • Brain Cancer Services
  • Breaking News
  • Breast Care Center
  • Breast Care Center Services
  • Breast Care Services
  • Breast Feeding Support Group
  • Breastfeeding Class
  • Breastfeeding Class
  • Breastfeeding Class
  • Breastfeeding Class
  • Breastfeeding Class
  • Breastfeeding Support Group
  • Breastfeeding Support Group Meeting Dates
  • CALGB 10603: A Phase III Randomized, Double-Blind Study of Induction (Daunorubicin/Cytarabine) and Consolidation (High-Dose Cytarabine) Chemotherapy + Midostaurin (PKC412) (IND #101261) or Placebo in Newly Diagnosed Patients < 60 Years of Age With FLT3 Mutated Acute Myeloid Leukemia (AML)
  • CALGB 80101 Phase III Intergroup Trial of Adjuvant Chemoradiation After Resection of Gastric or Gastroesophageal Adenocarcinoma
  • Cardiac Catheterization
  • Cardiac Rehabilitation
  • Cardiac Surgery
  • Cardiology
  • Care for Cancer Walk
  • Careers
  • Careers - Current Openings
  • Careers - Disagree
  • Caregivers of the Mentally Ill
  • Caritas Holy Family Mission and Values
  • Caritas trauma center awarded Level III status
  • Carolyn L. Candiello, Director of Quality & Safety
  • Carotid Revascularization Endarterectomy vs Stenting Trial (CREST)
  • Carotid Revascularization with ev3 Arterial Technology Evolution Post Approval Study (CREATE PAS)
  • Carotid Stenting for High Surgical-Risk Patients: Evaluating Outcomes Through the Collection of Clinical Evidence (“CHOICE”)
  • Catherine Philbin, Director of Foundation
  • Child Safety
  • Childbirth Education
  • Children Who Witness Domestic Violence
  • Chocolate and Roses: An Evening to Celebrate Women
  • Cisplatin, Irinotecan and Bevacizumab (NSC #704865, IND #7921) for Untreated Extensive Stage Small Cell Lung Cancer: A Phase II Study
  • Clinical Partners
  • Clinical Pastoral Education
  • Clinical Pastoral Education
  • Clinical Trials
  • Clinical Trials & Research
  • Clinical Trials and Research Display
  • Clinical Trials and Research Listing
  • Clinical Wizards
  • Colorectal Cancer Services
  • Community Involvement
  • Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
  • Comparison of the SUpera® PERipheral System to a Performance Goal derived from Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery (The SUPERB Study) Carotid Trial
  • Condition Index
  • CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
  • Contact Us
  • Contacts
  • Continence / Pelvic Floor Services
  • Coral: Cardiovascular Outcomes in Renal Atherosclerotic Lesions Randomized and Multi-Center Two-Group Clinical Trial to Assess the Best Treatment for Patients with High Blood Pressure and Renal Artery Stenosis: Stenting with Anti-Hypertensive Medical Therapy Compared to Medical Therapy Alone
  • CPE Application Form
  • CPR for Friends and Family - Infants
  • CPR for Friends and Family - Infants
  • CPR for Friends and Family - Infants
  • CPR for Friends and Family - Infants
  • CPR for Friends and Family - Infants
  • Critical Care Unit & Progressive Care Unit
  • Cyclophosphamide And Doxorubicin (CA) (4 VS 6 Cycles) Versus Paclitaxel (4 VS 6 Cycles) As Adjuvant Therapy For Breast Cancer in Women With 0-3 Positive Axillary Lymph Nodes:A 2X2 Factorial Phase III Randomized Study
  • Cytogenetic Studies in Leukemia Patients
  • Cytokine and Neutrophil Gene Polymorphisms: Novel Predictors of Acute Renal Failure Following Cardiac Pulmonary Bypass
  • Cytokine Gene Polymorphisms in Acute Renal Failure
  • Danielle Perry, Director of Marketing and Public Relations
  • Deb Bradshaw, Director of Human Resources
  • DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
  • Diabetes
  • Diabetes Support Group
  • Diabetes Support Group - Holiday Party
  • Diabetes Support Group Lecture Series - Know Your Resistance
  • Diagnostic Imaging
  • Digestive Diseases
  • Digital Mammography Services
  • Directions
  • Disclaimer
  • Disease & Wellness
  • Docetaxel plus 6-month androgen suppression and radiation therapy versus 6-month androgen suppression and radiation therapy for patients with high-risk localized or locally advanced prostate cancer: A randomized controlled trial
  • Donate Online
  • Dorairaju Thavaseelan, M.D., Chief of Anesthesia
  • Double-Blind, Placebo-Controlled, Multicenter Acute Study of Clinical Effectiveness of Nesiritide in Subjects With Decompensated Heart Failure (ASCEND-HF)
  • Dr. Shetty Profile
  • DX-88 (Ecallantide) for the Reduction of Blood Loss Associated With Cardiopulmonary Bypass: A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study in Patients Undergoing Primary Coronary Artery Bypass Grafting, Single Valve Repair or Single Valve Replacement
  • E1505 A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients With Completely Resected Stage IB-IIIA Non-Small Lung Cancer (NSCLC)
  • E2805: ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
  • E5103: A Double-Blind Phase III Trial of Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab or Placebo in Patients With Lymph Node Positive and High Risk Lymph Node Negative Breast Cancer
  • Ear, Nose and Throat
  • Elder Care
  • Electrophysiology
  • Email A Patient
  • Email a Patient - Form Submission Successful
  • Emergency Department Home
  • Employment Benefits
  • Endocrine Therapy With or Without Inhibition of EGF and HER2 Growth Factor Receptors: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Fulvestrant With or Without Lapatinib (GW572016) for Postmenopausal Women With Hormone Receptor Positive Advanced Breast Cancer
  • Endocrinology
  • Eric Miller, MD
  • Evaluating the Use of the FiberNet® Embolic Protection System in Carotid Artery Stenting: The EPIC US Pivotal Study
  • Extension to CFTY720D2309 (24-month Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing the Efficacy and Safety of 0.5 mg and 1.25 mg Fingolimod [FTY720] Administered Orally Once Daily Versus Placebo in Patients With Relapsing-remitting Multiple Sclerosis [RRMS])
  • Family and Friends CPR
  • Family and Friends CPR
  • Family and Friends CPR
  • Family and Friends CPR
  • Family and Friends CPR
  • Family Safety Project
  • Family Safety Project
  • Feasibility Study of a Behavioral Intervention for Women at Persistent High Risk for HIV Infection
  • Financial Information
  • Fitting the female form: Do new prosthetic knees for women really make a difference?
  • Flu Season Alert
  • For Clinicians
  • For Professionals
  • For Professionals
  • Foreign Language Information
  • Free Head & Neck Cancer Screening
  • FREE Skin Cancer Screening
  • Freedom from Monthly Bleeding - Endometrial Ablation: Alternative to Hysterectomy
  • Fundraising Events
  • General Donation
  • Genetic Analysis of Patients With Pseudoxanthoma Elasticum (PXE)
  • Gore Embolic Filter in Carotid Stenting for High Risk Surgical Subjects (GORE EMBOLDEN)
  • Gore Embolic Filter in Carotid Stenting for High Risk Surgical Subjects (Gore Embolden) Protocol GEF-06-08
  • Gore Viabahn Endoprosthesis with Heparin Bioactive Surface in the Treatment of Superficial Femoral Artery Obstructive Disease (VIPER)
  • Granite State Cancer Support Group - Sam Shetty, MD, Guest Speaker
  • Gynecological Cancer Services
  • Gynecology Services
  • H1N1 Flu (Swine Flu) - What You Need to Know
  • Haiti Relief Efforts
  • Han-Ting Lin, MD, Profile
  • Head & Neck Cancer Services
  • Health Library
  • Healthy Heart Event
  • Heart Care
  • Helpful Numbers
  • Hematology
  • High risk team partners with Holy Family to fight violent crime
  • High-Dose Rate Brachytherapy (HDR)
  • Hip Resurfacing Offers Alternative to Hip Replacement (Lecture)
  • Holy Family Hospital and WCAP980 AM Expert Network Segments
  • Holy Family Hospital’s National Cancer Survival Day
  • Home Care
  • Homecare Services for People with Diabetes
  • Honor Gift
  • Hospice
  • Hospital to acquire new cancer treatment technology
  • Hospitalists
  • How You Can Help: Make a Donation
  • Image Guided Radiation Therapy (IGRT)
  • Important Telephone Numbers
  • Induction Cisplatin/Irinotecan Followed By Combination Carboplatin, Etoposide And Chest Radiotherapy In Limited Stage Small Cell Lung Cancer: A Phase II Study
  • Infection Prevention
  • Injection of Autologous CD34-Positive Cells for Neovascularization and Symptom Relief in Patients With Myocardial Ischemia
  • Inner strength: Electronic implants provide hope for Parkinson’s sufferers to overcome symptoms
  • Inpatient Rehabilitation Services
  • Insulin Resistance Intervention After Stroke (IRIS) Trial
  • Intensity Modulated Radiation Therapy (IMRT)
  • Interactive Tools & Resources
  • Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil and Leucovorin vs Oxaliplatin, 5-Fluorouracil, Leucovorin and Bevacizumab for Patients With Stage II or III Rectal Cancer Receiving Pre-Operative Chemoradiation
  • Internal Medicine
  • Interpreter Services
  • January Senior Supper
  • Join
  • Kick the Habit: Quit Smoking – Smoking Cessation Program
  • Laboratory & Blood Bank Services
  • Lamaze Childbirth Classes - (weekdays)
  • Lamaze Childbirth Classes - (weekends)
  • Leaving the Hospital
  • Lester P. Schindel, President
  • Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
  • Living Our Values
  • Local doctors make a difference in Guatamala
  • Local family returns from eye-opening trip to Cambodia
  • Lung Cancer Services
  • Lung Cancer Specimen Repository Protocol, Ancillary
  • Main Page
  • Make a Donation
  • Mammography
  • MammoSite Targeted Radiation Therapy
  • Marty McDrury, Senior VP / COO
  • MASS COMM TRIAL- A randomized trial to Compare Percutaneous Coronary Intervention Between Massachusetts Hospital with Cardiac Surgery-On-Site and Community Hospital without Cardiac Surgery-On-Site.
  • Maternity Services
  • Media Coverage Home
  • Medical Oncology
  • Meet the Obstetricians / Gynecologists
  • Megan D'Eramo, Director of Physician Services
  • Men’s Guild
  • Merrimack Valley Ostomy Association
  • Mission & Values
  • Molecular Epidemiology Case-Series Study of Non-Small Cell Lung Cancer in Smoking and Non-Smoking Women and Men
  • Mukherjee Profile
  • Mukherjee Q&A Taking It To Heart
  • Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Oral Lixivaptan Capsules in Subjects with Euvolemic Hyponatremia
  • My Life, My Health
  • Nashua’s iCAD aims big by focusing small
  • National Cancer Survivors Day Luncheon
  • NECN Coverage of Caritas Christi Relief Team Departing For Haiti
  • Neurosciences
  • Neurosurgery
  • New England Pituitary Treatment Center
  • New Hampshire NeuroSpine Institute at Holy Family Hospital
  • News Via RSS
  • Newsletter
  • Newsletter Removal
  • Newsletter Signup
  • Newsletter Signup
  • Newsletter Unsubcribe
  • Newsroom
  • NO147: A Randomized Phase III Trial of Oxaliplatin (OXAL) Plus 5-Fluorouracil (5-FU)/Leucovorin (CF) With or Without Cetuximab (C225) After Curative Resection for Patients With Stage III Colon Cancer
  • Notes from the Field
  • Nutrition / Diabetes
  • Occupational Therapy
  • Other Cancers
  • Other Programs & Services Home
  • Our Physicians
  • Our System
  • p.VGI.1 (VEGF2) Gene Transfer for Diabetic Neuropathy
  • Pain Management
  • Pain Management
  • Pastoral Care
  • Pathology and Laboratory
  • Patient and Visitor Information Welcome
  • Patient Care Team
  • Patient Rights and Responsibilities
  • Patient, Family and Guest Services
  • Paul Allen, MD, MPH, Vice President of Medical Affairs
  • Pediatric Quality of Life Among Population With BMI Greater Than or Equal to 85%: Impact of a Behavioral Intervention Program
  • Pediatrics
  • Phase 1 Study of the Aeris Bronchoscopic Lung Volume Reduction (BLVR) System in Patients With Advanced Heterogeneous Emphysema
  • Phase 1 Study of the Biologic Lung Volume Reduction (BLVR) System in Patients With Advanced Upper Lobe Predominant Emphysema
  • Phase 2 Study of the Biologic Lung Volume Reduction System (BLVR) in Patients With Advanced Upper Lobe Predominant Emphysema
  • Phase 3 Randomized, Rater- and Dose-Blinded Study Comparing 2 Annual Cycles of IV 12 mg and 24 mg Alemtuzumab to 3x Weekly SC Interferon Beta-1a (Rebif®) in Relapsing-Remitting Multiple Sclerosis Patients Who Have Relapsed on Therapy
  • Phase 3 Study of the Biologic Lung Volume Reduction (BLVR) System in Patients With Advanced Upper Lobe Predominant Emphysema
  • Phase II Evaluation of Aprepitant, Dexamethasone, and Palonosetron as Antiemetic Therapy in Breast Cancer Patients Receiving Doxorubicin in Combination with Cyclophosphamide
  • Phase II study of Docetaxel and atrasentan versus docetaxel and placebo for patients with advanced hormaone refractory prostate cancer.
  • Phase II Trial of Androgen Suppression for 6 Months Combined With External Beam Radiotherapy (EBRT) With Brachytherapy (BT) Boost for Intermediate Risk Prostate Cancer
  • Phase II Trial of Simple Oral Therapy (Continuous Oral Cyclophosphamide and Capecitabine) in Patients With Metastatic Breast Cancer
  • Phase II, Randomized Study of Concomitant Chemoradiation Using Weekly Carboplatinum/Paclitaxel With (Arm A) or Without (Arm B) Daily Subcutaneous Amifostine in Patients With Newly Diagnosed Locally Advanced Squamous Cell Cancer of the Head and Neck
  • Phase III Chemoprevention Trial Of Selenium Supplementation In Persons With Resected Stage I Non-Small Cell Lung Cancer
  • Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
  • Phase III Randomized Study of TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Liposomal Doxorubicin (Doxil) as Second-Line Therapy in Platinum Refractory or Resistant Ovarian Cancer [ASSIST-3]
  • Phase III Randomized Trial of Anastrozole Versus Anastrozole and Fulvestrant as First Line Therapy for Post Menopausal Women With Metastatic Breast Cancer
  • Phase III Study of Docetaxel and Atrasentan Versus Docetaxel and Placebo for Patients With Advanced Hormone Refractory Prostate Cancer
  • Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer
  • Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
  • Phase III Trial of Tamoxifen Alone vs. Tamoxifen Plus RT for Good Risk Duct Carcinoma In-Situ (DCIS) of the Female Breast
  • Physical Therapy
  • Physical Therapy, Occupational Therapy, Speech Therapy
  • Physical Therapy, Occupational Therapy, Speech Therapy
  • Pituitary Services
  • Pivotal/Phase III Multicentered, Two-Arm, Randomized Study Comparing the Effects of AAT-023 Solution (Zuragen), and Heparin on the Incidence of Catheter Related Blood Stream Infections in Tunneled Chronic Central Venous Catheters for Dialysis
  • Plastic Surgery
  • Pre-Admission Services
  • Prevention
  • Printer Friendly Directions
  • Privacy Policy
  • Prospective Evaluation of Elastic Restraint to LESSen the Effects of Heart Failure (PEERLESS-HF) Trial
  • Prospective Evaluation of the Incidence of Nausea and Vomiting in Patients With Colorectal Cancer Receiving Irinotecan-Based Therapy
  • Prostate Cancer Services
  • Prostate Seed Implants
  • PROTECTed Carotid Artery Stenting in Subjects at High Risk for Carotid Endarterectomy (CEA)
  • Psychiatry
  • Pulmonary
  • Pulmonary Medicine
  • Quality and Clinical Excellence
  • Quality and Patient Satisfaction
  • Quality of Life, Employment and Informal Care Cost Analysis in Women Receiving Adjuvant Chemotherapy for Breast Cancer With 0-3 Positive Axillary Lymph Nodes
  • RADIANT: A Multi-center, Randomized, Double-blind, Placebo-controlled, Phase 3 Study of Single-agent Tarceva® (Erlotinib) Following Complete Tumor Resection With or Without Adjuvant Chemotherapy in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma Who Have EGFR-positive Tumors
  • RADIANT: Phase II Trial Of OSI-774 (NSC-718781) In Patients With Advanced Non-Small Cell Lung Cancer And A Performance Status Of 2
  • Radiation Oncology
  • Radiation Oncology Services
  • Radiology
  • Randomized Placebo-Controlled Trial of Acetyl-L-Carnitine (ALC) for the Prevention of Taxane Induced Neuropathy Phase III
  • Regional Center for Orthopedic Care
  • Rehabilitation Services
  • RENEW: Women's Health and Wellness Fair
  • RENEW: Women's Health and Wellness Fair
  • Request More Information
  • Revised Protocol 07 to Protocol CA225006 - A Phase III Randomized, Open-Label, Multicenter Study of Irinotecan and Cetuximab vs. Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Carcinoma
  • Schizophrenics Anonymous
  • Senior Leadership Team
  • Senior Supper
  • Services and Clinical Centers
  • Shirley Albert-Pressman, Vice President for Business Development
  • Sibling Preparation Class
  • Sibling Preparation Class
  • Sibling Preparation Class
  • Sibling Preparation Class
  • Sleep Apnea
  • Sleep Disorder Center
  • Sleep Medicine Services
  • Smoking Cessation
  • SO720: Phase II ERCC1 and RRM1-Based Adjuvant Therapy Trial in Patients With Stage I Non-Small Cell Lung Cancer (NSCLC)
  • SO819: A Randomized, Phase III Study Comparing Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab With or Without Concurrent Cetuximab in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
  • Social Work Services
  • SONOMA: The NexStentâ Carotid Stent System: A Post Market Approval Evaluation Study in conjunction with the Boston Scientific FilterWire EZ Embolic Protection System
  • Spanish Diabetes Support Group - Rosa's Story, La Historia de Rosa
  • Speech Therapy
  • Spiritual Care
  • Sports Injuries: Get Ready for Springtime Sports
  • Sports Medicine & Outpatient Rehabilitation
  • Stenting and Angioplasty with Protection in Patients at High-Risk For Endarterectomy-Sapphire WW (Protocol# P06-3603)
  • Stereotactic RadioSurgery (SRS)
  • Stereotactic RadioTherapy (SRT)
  • Stroke Services
  • Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
  • Subscribe to Wellness Matters
  • Surgical Oncology
  • Surgical Services
  • Sustaining Cessation in Smokers With Kids With Asthma
  • TAILORx: Program for the Assessment of Clinical Cancer Tests (PACCT-1): Trial Assigning Individualized Options for Treatment: The TAILORx Trial
  • Taking a closer look allows earlier detection of breast cancer
  • Test
  • Test
  • Tests & Procedures
  • Tests & Procedures List
  • Thank You
  • The Caritas Centers for Sleep Medicine
  • The Effect of Vaginal Progesterone Administration in the Prevention of Preterm Birth in Women With a Short Cervix [Vaginal Progesterone Bioadhesive Gel (Prochieve)® Extending Gestation A New Therapy for Short Cervix - Trial (PREGNANT Short Cervix - Trial)]
  • The Effects of Eszopiclone and Lexapro on Prefrontal Glutamate and GABA in Depression With Co-morbid Anxiety and Insomnia: A Proton MRS Study
  • The Harbinger ICD Patient (HIP) Study
  • The New England Regional Stroke Center
  • The NexStent® Carotid Stent System: A Post Market Approval Evaluation Study In Conjunction With the FilterWire EZ™ Embolic Protection System
  • THE REVOLUTION IS HERE. AND IT'S HIRING.
  • Thomas K. Sager, CEO
  • Thoracic Surgery
  • Tips on How to Manage Pain
  • To Find the Best Dose of pVGI.1(VEGF2) to Benefit Angina Patients When Given With an Experimental Injection Catheter
  • Tom Sager Golf Classic
  • Trial of Aldosterone Antagonist Therapy in Adults With Preserved Ejection Fraction Congestive Heart Failure (TOPCAT)
  • Trilogy Stereotactic System
  • Type 2 Diabetes and Obesity Pediatric Prevention Project
  • Urology
  • Validation of Serum Markers as a Bioassay for Unipolar Depression
  • Vascular Surgery
  • VEGF Gene Transfer for Critical Limb Ischemia
  • Video Test Page
  • Volunteer Your Time
  • Ways of Giving
  • Welcome Newborn
  • What's New at Caritas Holy Family
  • Why go to Boston? Valley hospitals make pitch for patients to stay local
  • William L. Lane Cancer Management Center
  • Women’s Auxiliary
  • Women's Health
  • Women's Health Network
  • Women's Imaging
  • World-Class Cancer Care Is A Team Effort
  • Wound Clinic
  • Wound nurse is lauded for her research
  • YMCA Membership Appreciation Day
  • Your briefcase

Site Map | Disclaimer | Privacy Policy | Contact Us

Copyright © 2010 Caritas Christi